VII. Management of nodular lymphocyte‐predominant Hodgkin lymphoma
Authors:
- 17 June 2013
- journal article
- review article
- Published by Wiley in Hematological Oncology
- Vol. 31 (S1) , 47-50
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcomeBlood, 2011
- Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study GroupBlood, 2011
- Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2011
- Lymphocyte-predominant Hodgkin lymphoma—clinical features and treatment outcomes from a 30-year experienceAnnals of Oncology, 2010
- Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's LymphomaJournal of Clinical Oncology, 2010
- Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-UpJournal of Clinical Oncology, 2010
- Nodular, lymphocyte‐predominant Hodgkin lymphomaCancer, 2009
- Lymphocyte-Predominant and Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study GroupJournal of Clinical Oncology, 2008
- High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Lymphocyte Predominant Hodgkin’s Disease.Blood, 2006
- Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG)Annals of Oncology, 2005